Business Award - April 27, 2026
SerendoTx wins AbbVie Scandinavia Golden Ticket 2026
Serendo Therapeutics (SerendoTx) has been named the winner of the AbbVie Scandinavia Golden Ticket 2026, awarded in collaboration with Karolinska Institutet Innovation.
Acquisition - April 27, 2026
AddLife acquires CoaChrom Diagnostica
AddLife has acquired CoaChrom Diagnostica, an Austrian niche company specializing in advanced coagulation diagnostics.
Science News - April 26, 2026
New clinical center for vision research launched in Stockholm
Sweden’s first clinical research center dedicated to ophthalmology has been established at St. Erik Eye Hospital in the Stockholm Region, in collaboration with Karolinska Institutet.
Global report - April 24, 2026
Biogen in agreement with TJ Biopharma
The companies have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio’s exclusive rights to felzartamab in the Greater China Region.
Clinical Trials - April 24, 2026
Takeda reports additional Phase 3 clinical insights on TAK-279
Takeda has announced new data, presented at the 2026 American Academy of Dermatology (AAD), from two Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).
Sweden - April 21, 2026
Stable Swedish health exports despite an uncertain surrounding world
This is according to Swecare's Health Export Barometer 2026 launched today, April 21.
